Instrument Inactif

Autres langues Nanoform Finland Oyj Nasdaq Helsinki

Actions

FI4000330972

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Nanoform Finland Plc - Manager's Transactions - Miguel Calado	14/06
Nanoform Finland Plc - Manager's Transactions - Mads Laustsen	14/06
Nanoform Finland Plc - Manager's Transactions - Albert Hæggström	14/06
Nanoform Finland Plc - Manager's Transactions - Jeanne Thoma	14/06
Share subscriptions based on the resolution by Nanoform Finland Plc's Annual General Meeting 2024 on remuneration of the Board of Directors	14/06
Nanoform Finland Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	30/05
Nanoform Finland Oyj : Interim Report for January-March 2024 Report	30/05
Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned	30/05
Disclosure of Major Holdings under Law 163/2024	29/05
Invitation to Nanoform's Q1 2024 Report Presentation	16/05
Nanoformed High-Concentration Biologics Formulation for Subcutaneous Delivery Results to be Presented by Takeda at DDF Summit	07/05
Disclosure of Major Holdings under Law 163/2024	26/04
New shares of Nanoform registered with the trade register	25/04
Nanoform successfully completes new share issue raising EUR 15.4 million to invest in commercialization of nanoparticle enabled formulations for next generation medicines	24/04
Nanoform announces its intention to carry out a new share issue of approximately 7 million new shares to invest in commercialization of nanoparticle enabled formulations for next generation medicines	24/04
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc	16/04
Resolutions of Nanoform Finland Plc's Annual General Meeting on April 16, 2024	16/04
Nanoform Finland to Deliver Nanomedicine Technology to Japan	11/04
Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan	11/04
Nanoform Enters Exclusive Partnership with CBC to Bring Best-In-Class Nanomedicine Technology to Japan	11/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Nanoform Finland Oyj Nasdaq Helsinki

Actions

FI4000330972

Autres langues

Filtres